Innovation
1 patent family (1 granted) — focus: Human necessities; filing pace dormant. Cited 33 times.
| Year | Filings |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
Investor mix
4 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 75% |
| Other / undisclosed | 1 | 25% |
Preclinical CRO specializing in anti-inflammatory and anti-fibrotic drugs
1 patent family (1 granted) — focus: Human necessities; filing pace dormant. Cited 33 times.
| Year | Filings |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
4 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 75% |
| Other / undisclosed | 1 | 25% |